Summarized by Masters of Longevity from Frontiers - Health.
A review synthesizes recent studies on microRNA roles in multiple myeloma biology, diagnostics, prognostication, and miRNA-based therapeutic strategies.
Key Takeaways
- MiRNAs are implicated in MM onset, progression, recurrence, and drug resistance in recent studies.
- Circulating and exosomal miRNAs show promise as diagnostic and prognostic biomarkers for MM patients.
- Preclinical miRNA-targeted therapies demonstrate efficacy but face delivery and standardization challenges.
